253 related articles for article (PubMed ID: 35089958)
1. Identification of pharmacogenetic variants from large scale next generation sequencing data in the Saudi population.
Goljan E; Abouelhoda M; ElKalioby MM; Jabaan A; Alghithi N; Meyer BF; Monies D
PLoS One; 2022; 17(1):e0263137. PubMed ID: 35089958
[TBL] [Abstract][Full Text] [Related]
2. Large-scale next generation sequencing based analysis of SLCO1B1 pharmacogenetics variants in the Saudi population.
Goljan E; Abouelhoda M; Tahir A; ElKalioby M; Meyer B; Monies D
Hum Genomics; 2024 Mar; 18(1):30. PubMed ID: 38523294
[TBL] [Abstract][Full Text] [Related]
3. Results of the implementation of a pharmacogenomics platform based on NGS technologies. Combining clinical and research approaches.
Ramudo-Cela L; Busto-Fernández F; Outeda-Macías M; Antolín S; Calvo-Martínez L; Martín-Herranz I
Farm Hosp; 2021 Dec; 45(7):11-37. PubMed ID: 35379108
[TBL] [Abstract][Full Text] [Related]
4. Novel copy-number variations in pharmacogenes contribute to interindividual differences in drug pharmacokinetics.
Santos M; Niemi M; Hiratsuka M; Kumondai M; Ingelman-Sundberg M; Lauschke VM; Rodríguez-Antona C
Genet Med; 2018 Jun; 20(6):622-629. PubMed ID: 29261188
[TBL] [Abstract][Full Text] [Related]
5. Characterization of ADME Gene Variation in Colombian Population by Exome Sequencing.
Silgado-Guzmán DF; Angulo-Aguado M; Morel A; Niño-Orrego MJ; Ruiz-Torres DA; Contreras Bravo NC; Restrepo CM; Ortega-Recalde O; Fonseca-Mendoza DJ
Front Pharmacol; 2022; 13():931531. PubMed ID: 35846994
[TBL] [Abstract][Full Text] [Related]
6. Computational pharmacogenotype extraction from clinical next-generation sequencing.
Shugg T; Ly RC; Osei W; Rowe EJ; Granfield CA; Lynnes TC; Medeiros EB; Hodge JC; Breman AM; Schneider BP; Sahinalp SC; Numanagić I; Salisbury BA; Bray SM; Ratcliff R; Skaar TC
Front Oncol; 2023; 13():1199741. PubMed ID: 37469403
[TBL] [Abstract][Full Text] [Related]
7. Development of the PGx-Passport: A Panel of Actionable Germline Genetic Variants for Pre-Emptive Pharmacogenetic Testing.
van der Wouden CH; van Rhenen MH; Jama WOM; Ingelman-Sundberg M; Lauschke VM; Konta L; Schwab M; Swen JJ; Guchelaar HJ
Clin Pharmacol Ther; 2019 Oct; 106(4):866-873. PubMed ID: 31038729
[TBL] [Abstract][Full Text] [Related]
8. Genotypic and phenotypic landscapes of 51 pharmacogenes derived from whole-genome sequencing in a Thai population.
Wankaew N; Chariyavilaskul P; Chamnanphon M; Assawapitaksakul A; Chetruengchai W; Pongpanich M; Shotelersuk V
PLoS One; 2022; 17(2):e0263621. PubMed ID: 35176049
[TBL] [Abstract][Full Text] [Related]
9. Clinical pharmacogenetic analysis in 5,001 individuals with diagnostic Exome Sequencing data.
Lanillos J; Carcajona M; Maietta P; Alvarez S; Rodriguez-Antona C
NPJ Genom Med; 2022 Feb; 7(1):12. PubMed ID: 35181665
[TBL] [Abstract][Full Text] [Related]
10. Variant discovery using next-generation sequencing and its future role in pharmacogenetics.
Russell LE; Schwarz UI
Pharmacogenomics; 2020 May; 21(7):471-486. PubMed ID: 32338137
[TBL] [Abstract][Full Text] [Related]
11. Genetic Variation among Pharmacogenes in the Sardinian Population.
Idda ML; Zoledziewska M; Urru SAM; McInnes G; Bilotta A; Nuvoli V; Lodde V; Orrù S; Schlessinger D; Cucca F; Floris M
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077453
[TBL] [Abstract][Full Text] [Related]
12. Analysis of population-specific pharmacogenomic variants using next-generation sequencing data.
Ahn E; Park T
Sci Rep; 2017 Sep; 7(1):8416. PubMed ID: 28871186
[TBL] [Abstract][Full Text] [Related]
13. Actionable pharmacogenetic variants in Hong Kong Chinese exome sequencing data and projected prescription impact in the Hong Kong population.
Yu MHC; Chan MCY; Chung CCY; Li AWT; Yip CYW; Mak CCY; Chau JFT; Lee M; Fung JLF; Tsang MHY; Chan JCK; Wong WHS; Yang J; Chui WCM; Chung PHY; Yang W; Lee SL; Chan GCF; Tam PKH; Lau YL; Tang CSM; Yeung KS; Chung BHY
PLoS Genet; 2021 Feb; 17(2):e1009323. PubMed ID: 33600428
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetic relevant polymorphisms of CYP2C9, CYP2C19, CYP2D6, and CYP3A5 in Bhutanese population.
Dorji PW; Wangchuk S; Boonprasert K; Tarasuk M; Na-Bangchang K
Drug Metab Pers Ther; 2019 Dec; 34(4):. PubMed ID: 32004143
[TBL] [Abstract][Full Text] [Related]
15. Genetic Analysis of Pharmacogenomic VIP Variants of ABCB1, VDR and TPMT Genes in an Ethnically Isolated Population from the North Caucasus Living in Jordan.
Al-Eitan LN; Al-Maqableh HW; Mohammad NN; Hakooz NM; Dajani RB
Curr Drug Metab; 2020; 21(4):307-317. PubMed ID: 32368972
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of exposure to pharmacogenetic drugs by the Saudis treated at the health care centers of the Ministry of National Guard.
Alshabeeb MA; Alyabsi M; Paras B
Saudi Pharm J; 2022 Aug; 30(8):1181-1192. PubMed ID: 36164570
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive overview of the pharmacogenetic diversity in Ashkenazi Jews.
Zhou Y; Lauschke VM
J Med Genet; 2018 Sep; 55(9):617-627. PubMed ID: 29970487
[TBL] [Abstract][Full Text] [Related]
18. Integrating rare genetic variants into pharmacogenetic drug response predictions.
Ingelman-Sundberg M; Mkrtchian S; Zhou Y; Lauschke VM
Hum Genomics; 2018 May; 12(1):26. PubMed ID: 29793534
[TBL] [Abstract][Full Text] [Related]
19. Targeted Genotyping in Clinical Pharmacogenomics: What Is Missing?
Lopes JL; Harris K; Karow MB; Peterson SE; Kluge ML; Kotzer KE; Lopes GS; Larson NB; Bielinski SJ; Scherer SE; Wang L; Weinshilboum RM; Black JL; Moyer AM
J Mol Diagn; 2022 Mar; 24(3):253-261. PubMed ID: 35041929
[TBL] [Abstract][Full Text] [Related]
20. Targeted Next-Generation Sequencing for Comprehensive Genetic Profiling of Pharmacogenes.
Han SM; Park J; Lee JH; Lee SS; Kim H; Han H; Kim Y; Yi S; Cho JY; Jang IJ; Lee MG
Clin Pharmacol Ther; 2017 Mar; 101(3):396-405. PubMed ID: 27727443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
